Cargando…

CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current Insights

CD24 is a highly glycosylated glycophosphatidylinositol (GPI)-anchored protein that is expressed in many types of differentiating cells and some mature cells of the immune system as well as the central nervous system. CD24 has been extensively used as a biomarker for developing B cells as its expres...

Descripción completa

Detalles Bibliográficos
Autor principal:	Christian, Sherri L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680537/ https://www.ncbi.nlm.nih.gov/pubmed/36425299 http://dx.doi.org/10.2147/OTT.S366625

Ejemplares similares

CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
por: Freile, Jimena Álvarez, et al.
Publicado: (2022)

CD24: A Rheostat That Modulates Cell Surface Receptor Signaling of Diverse Receptors
por: Ayre, D. Craig, et al.
Publicado: (2016)

CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
por: Li, Ziduo, et al.
Publicado: (2018)

CD81 as target for B cell lymphomas
por: Küppers, Ralf
Publicado: (2019)

Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
por: Karnan, Sivasundaram, et al.
Publicado: (2020)

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia
por: Lo, Tsun-Ho, et al.
Publicado: (2019)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas
por: Orlova, Anna, et al.
Publicado: (2017)

Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma
por: Gao, Minjie, et al.
Publicado: (2016)

B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy
por: Alam, Manzar, et al.
Publicado: (2021)

B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy
por: Zhang, Xiaohui, et al.
Publicado: (2017)

Targeting the CD47-SIRPα signaling axis: current studies on B-cell lymphoma immunotherapy
por: Zhang, Jin, et al.
Publicado: (2018)

CD70‐targeting CAR‐T cells have potential activity against CD19‐negative B‐cell Lymphoma
por: Deng, Wenhai, et al.
Publicado: (2021)

CD24 is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma
por: Higashi, Morihiro, et al.
Publicado: (2022)

Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances
por: Liu, Jile, et al.
Publicado: (2023)

CD24 induces changes to the surface receptors of B cell microvesicles with variable effects on their RNA and protein cargo
por: Ayre, D. Craig, et al.
Publicado: (2017)

Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma
por: Rauch, Daniel A., et al.
Publicado: (2020)

Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool
por: Kalinkova, Lenka, et al.
Publicado: (2022)

Revisiting CD28 Superagonist TGN1412 as Potential Therapeutic for Pediatric B Cell Leukemia: A Review
por: Brown, Katelyn E.
Publicado: (2018)

CD24 is required for regulating gene expression, but not glucose uptake, during adipogenesis
por: Smith, Nicole C., et al.
Publicado: (2018)

Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas
por: Chu, Fuliang, et al.
Publicado: (2023)

Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review
por: Tsioulos, Georgios, et al.
Publicado: (2022)

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
por: Pang, Yuyang, et al.
Publicado: (2023)

Novel therapeutic targets in diffuse large B-cell lymphoma
por: Lenz, Georg
Publicado: (2013)

CD81 is a novel immunotherapeutic target for B cell lymphoma
por: Vences-Catalán, Felipe, et al.
Publicado: (2019)

CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma
por: Gambella, Massimiliano, et al.
Publicado: (2022)

Repression of CD24 surface protein expression by oncogenic Ras is relieved by inhibition of Raf but not MEK or PI3K
por: Pallegar, Nikitha K., et al.
Publicado: (2015)

Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights
por: Chatterjee, Annesha, et al.
Publicado: (2023)

Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia
por: Di Martino, Ludovica, et al.
Publicado: (2021)

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma
por: Katsuya, Hiroo, et al.
Publicado: (2018)

Altered N-Linked Glycosylation in Follicular Lymphoma and Chronic Lymphocytic Leukemia: Involvement in Pathogenesis and Potential Therapeutic Targeting
por: Hollander, Nurit, et al.
Publicado: (2017)

Lysosomes in acute myeloid leukemia: potential therapeutic targets?
por: Rafiq, Sreoshee, et al.
Publicado: (2021)

Metastatic Potential of Lymphoma/Leukemia Cell Lines in SCID Mice Is Closely Related to Expression of CD44
por: Kawasaki, Nobuhiro, et al.
Publicado: (1996)

CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease
por: Teh, Yoong Mond, et al.
Publicado: (2021)

Development of a Bispecific Nanobody Targeting CD20 on B-Cell Lymphoma Cells and CD3 on T Cells
por: Liu, Yanlong, et al.
Publicado: (2022)

T follicular helper cells: a potential therapeutic target in follicular lymphoma
por: Ochando, Jordi, et al.
Publicado: (2017)

CD52 and OXPHOS—potential targets in ibrutinib-treated mantle cell lymphoma
por: Fuhr, Viktoria, et al.
Publicado: (2022)

Targeting CD19 in B-cell lymphoma: emerging role of SAR3419
por: Raufi, Ali, et al.
Publicado: (2013)

Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20(+) B-cell lymphoma
por: Nevala, Wendy K., et al.
Publicado: (2017)

Novel Insights and Current Evidence for Mechanisms of Atherosclerosis: Mitochondrial Dynamics as a Potential Therapeutic Target
por: Li, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oni47hhhlbljh3k25lvodqus4k